Deep learning is reshaping clinical trial design, execution, and analysis. Learn how to deploy it safely, measurably, and at scale with help from life sciences consultant and MIT industry advisor Partha Anbil.
- Avoid Clinical Alignment Breakdowns With "Lateral Agility"
- Why Africa Could Be The Next Frontier For Clinical Trials
- The Latest On RBM Uptake? Tufts Says Most, But Not All, Pharma On Board
- FDA's Draft Guidance On Bayesian Methods: Strategic Implications For Small Biotechs
- How Keenova Reignited A Stalled Trial
- Adapt Or Die: Best Practices In Designing An Adaptive, Open-Label RCT Phase 3 Oncology Trial
- The Uncomfortable Conversation: AI And Data Use In Clinical Trials
GUEST COLUMNISTS
-
![AI-Artificial Intelligence in Healthcare-GettyImages-1365534802]( "The Uncomfortable Conversation: AI And Data Use In Clinical Trials")
The Uncomfortable Conversation: AI And Data Use In Clinical TrialsAI is quietly transforming clinical trials at the site level, boosting efficiency while creating hidden risks for patient data, protocols, and sponsor intellectual property.
-
![Chat bot service, future marketing-GettyImages-1468141962]( "When A Clinical Trial Surfaces In An AI Chat, What Happens Next?")
When A Clinical Trial Surfaces In An AI Chat, What Happens Next?AI is soon becoming the first interpreter of your clinical trial. Understand its implications for enrollment design, screening efficiency, and ultimately program predictability.
-
![Contracting, signing business investment-GettyImages-1370104932]( "The Cost Of Transactional Thinking In Clinical Research")
The Cost Of Transactional Thinking In Clinical ResearchDenise N. Bronner of Empactful Ventures explores the power dynamics at play in clinical research, picking apart the roles of sponsors, vendors, and sites and advocating for a better way to do business among them.
-
![Medical cloud technology, digital healthcare data storage, data management-GettyImages-2204263083]( "Enabling Cloud Computing In DCTs For Remote Data Capture, Monitoring, And More (Part 1)")
Enabling Cloud Computing In DCTs For Remote Data Capture, Monitoring, And More (Part 1)Understand why cloud infrastructure is foundational to hybrid and decentralized trials and what critical trial activities it enables with reduced operational friction.
-
![cloud data, cloud storage, digital health records, telemedicine technology-GettyImages-2253333942]( "Safe And Sustainable DCTs and Hybrid Trials (Part 2)")
Safe And Sustainable DCTs and Hybrid Trials (Part 2)In part two of this series, learn practical cloud architectural patterns, governance structures, and operating mechanisms that allow sponsors to run hybrid and decentralized trials.
-
![Hospital management meeting-GettyImages-1134045124]( "Why Sponsors Should Share KPI Rationale With Sites")
Why Sponsors Should Share KPI Rationale With SitesTo build partnerships, foster transparency, and promote shared accountability, Curo Research CEO Amy Bland explains why sponsors need to communicate the utility of KPIs with sites.
-
![Parkinson's symptoms-GettyImages-1688988054]( "Rethinking Clinical Trials In Rare Neurodegenerative Diseases: Lessons From Alterity's MSA Trial")
Rethinking Clinical Trials In Rare Neurodegenerative Diseases: Lessons From Alterity's MSA TrialAlterity Therapeutics CEO David Stamler shares how early diagnosis, biomarker-guided design, and precise patient selection positively impacted a trial in multiple system atrophy (MSA).
-
![GettyImages-1602744313 assay]( "Breaking Through Tumor Defenses With Next-Generation Cell Therapy")
Breaking Through Tumor Defenses With Next-Generation Cell TherapyErnexa Therapeutics CEO Sanjeev Luther shares how clinical research has revealed why certain cancers resist treatment and how emerging cell therapies may help break through those defenses.
CLINICAL TRIAL WHITE PAPERS
-
![GettyImages-1278800031 diverse trial participants]( "Completed Clinical Trials, Terminations Both Rose In 2023")
Completed Clinical Trials, Terminations Both Rose In 2023This white paper highlights how the widespread growth in completed trials is coupled with higher success rates across multiple therapeutic areas, signaling the end of pandemic-related disruptions and infectious disease-related activity after three years of fluctuations.
-
If Data Integrity Matters, Paper Is Not An Option3/5/2026
Ditch outdated paper assessments to ensure data integrity. Digital capture improves regulatory compliance, reduces administrative burden, and enhances the patient experience in clinical trials.
-
Eliminate Clinical Trial White Space With The Right AI Strategy10/9/2025
Learn how sponsors and CROs are using agentic AI to eliminate the unproductive time caused by manual, sequential processes and fragmented data systems.
-
Pharma R&D Review 2024: Pleasant Weather Ahead5/16/2024
Gain insights from the 2024 pharma landscape, which reports a record-breaking 22,825 pipeline drugs, led by Pfizer's 32 new candidates and a strong focus on oncology and neurological treatments.
-
Merits Of A Multifaceted Approach To Clinical Trial Recruitment1/27/2025
The best way to address clinical trial recruitment challenges is with a multifaceted approach that goes beyond traditional channels and ways of thinking.
-
Blueprint For Early Phase Clinical Pharmacology Studies In Dermatology4/11/2025
Explore the landscape of dermatological drug development through a comprehensive framework for rational early-phase dermatological trials, centered around five foundational pillars.
CLINICAL TRIAL APP NOTES & CASE STUDIES
-
Enhancing Phase 1 Clinical Trials With Point-Of-Need Safety Assessments2/3/2025
A Mobile Clinical Suite (MCS) proved to be the solution that Syneos Health needed to resolve their Phase 1 study trial challenges with comprehensive eye exams.
-
RTSM And Clinical Drug Dispensation7/16/2024
A pharma company used Signant Health's RTSM solution in a Phase 2 schizophrenia trial to ensure drug availability, maintain study balance, prevent duplicate allocations, and manage returns and destruction of unused drugs.
-
Automated Trial Monitoring Workflows Make A Lean Team More Efficient1/7/2026
A pharmaceutical therapy developer was looking to automate reports, confirmation letters, and follow-up letters. See what happened when they adopted a cloud-based solution for end-to-end trial management.
-
Patient Caregiver Network Improves Post-Seizure Trial Data3/26/2024
Discover how a pharmaceutical CRO addressed concerns about seizure diary timing in a rare disease study, leveraging insights from Medable's Patient Community Network to optimize data collection.
-
Expanding Accessibility In A Phase 3 Influenza Study Through Community-Based Research10/6/2025
By meeting participants where they are, this study sets a new benchmark for inclusive, efficient, and impactful vaccine development.
-
Pay-By-Procedure Vs. Pay-By-Visit12/8/2025
Explore how a pay-by-procedure model can reshape site payments, enhance transparency, and reveal meaningful efficiencies across complex clinical trials.
NEWSLETTER ARCHIVE
- 03.10.26 -- When A Clinical Trial Surfaces In An AI Chat, What Happens Next?
- 03.09.26 -- Expanding Influenza Study Access Via Community-Based Research
- 03.06.26 -- How Regulatory Convergence Is Rewriting Clinical Data Management
- 03.06.26 -- Clinical Trial Software And eClinical Solutions
- 03.05.26 -- How To Lead A Moonshot Collaboration
RECRUITMENT AND DIVERSITY
This section includes some helpful resources regarding patient recruitment and diversity in clinical trials, including this link to the FDA's guidance on diversity action plans.
-
![Chat bot service, future marketing-GettyImages-1468141962]( "When A Clinical Trial Surfaces In An AI Chat, What Happens Next?")
AI is soon becoming the first interpreter of your clinical trial. Understand its implications for enrollment design, screening efficiency, and ultimately program predictability.
-
![Dietitian holding diet plan-GettyImages-1425188874]( "The Problem With Excluding Children From GLP-1 Trials In The U.S.")
In the U.S., roughly 15 million children are obese. But many are excluded from GLP-1 research. Obesity expert Evan Nadler, MD, explains why that's problematic.
-
![Woman using smartwatch-GettyImages-2248203064]( "How AI-Enabled Personal Health Tools Are Reshaping Clinical Trial Workflows")
Learn how AI-enabled personal health technologies are impacting key aspects of trial operations while also exploring operational challenges that clinical operations leaders must manage in this AI-driven era.
FOCUS ON PATIENTS
-
![Father playing with child-GettyImages-1567083882]( "Time Is Lives: How Collaboration And Urgency Are Rewriting The Future Of Rare Disease")
The inflection point has arrived, says Rob Freishtat, MD, MPH. Understand how collaboration will rewrite how we think of rare disease clinical research.
-
![Dietitian holding diet plan-GettyImages-1425188874]( "The Problem With Excluding Children From GLP-1 Trials In The U.S.")
In the U.S., roughly 15 million children are obese. But many are excluded from GLP-1 research. Obesity expert Evan Nadler, MD, explains why that's problematic.
-
![Woman using smartwatch-GettyImages-2248203064]( "How AI-Enabled Personal Health Tools Are Reshaping Clinical Trial Workflows")
Learn how AI-enabled personal health technologies are impacting key aspects of trial operations while also exploring operational challenges that clinical operations leaders must manage in this AI-driven era.
